Rethinking Trial Access in Lower-Income Regions
Expanding breast cancer research leadership beyond high-income countries is crucial for building more inclusive global trial networks.
Gen Li, PhD, MBA, president of Phesi, discussed the company's analysis on global inequity in breast cancer development in a recent video interview with Applied Clinical Trials.
- Geographic concentration of breast cancer trial leaders is primarily in the US and China.
- Traditional business models create operational barriers in lower-income countries.
- Artificial intelligence (AI) and machine learning can help implement a more patient-centric approach.
Identifying local leaders and redistributing trial workloads can improve recruitment and activate new sites.
Li emphasized the importance of leveraging AI to address the lack of local key opinion leaders (KOLs) in underserved areas.
A more patient-centric approach can help expand breast cancer research leadership globally.
Author's summary: Technology can help expand breast cancer research.
More News
- Watch: Zohran Mamdani’s ‘Dream’ resonates with Indian Muslims
- Breaking the cycle: A blueprint for special educational needs and disability (SEND) reform | IPPR
- The new immigration hot potato: How the ECHR was hijacked by the right
- 'A House Of Dynamite' Ending Explained – Can The U.S. Stop A Nuclear Missile? What Decision Does The President Make? | Trending News Buzz